The Challenge of HIV Diversity
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 15 April 2025 | Viewed by 2187
Special Issue Editor
Interests: HIV evolution; viral epidemiology; phylogenetic analyses; genetic recombination; viral taxonomy and nomenclature; HIV genotyping; HIV pathogenesis
Special Issue Information
Dear Colleagues,
Viruses invites the submission of original research and review articles to this Special Issue, covering challenges in HIV diversity. The articles can cover any level of diversity, from intrapatient immune evasion and development of drug resistance, to global challenges for vaccine design. Reports of research on HIV recombination at all levels, from intrapatient to inter-subtype, are encouraged. Although HIV-1 M-group viruses comprise the majority of global AIDS cases, submissions if research on other immunodeficiency viruses is also encouraged. Topics of interest can include challenges in methods (challenges of amplifying and sequencing viral genomes, for example) and computation (challenges with multiple sequence alignment, phylogenetic analyses, recombination detection, etc.). Analyses of trends in drug resistance, immune evasion or epidemiology are well suited for this Special Issue. Although submissions should focus on immunodeficiency viruses, comparisons or contrasts to other viruses can be illuminating and useful.
Dr. Brian T. Foley
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV diversity
- immune evasion
- drug resistance
- vaccine design
- HIV recombination
- immunodeficiency viruses
- epidemiology analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
